CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
002462 Cachet Pharmaceutical
- 11.94
- -0.04-0.33%
Market Closed Apr 30 15:00 CST
3.48BMarket Cap26.53P/E (TTM)
12.09High11.92Low19.80KlotVolume11.98Open11.98Pre Close23.74MTurnover0.68%Turnover Ratio21.67P/E (Static)291.71MShares14.5852wk High0.80P/B3.48BFloat Cap10.0252wk Low13.18Limit Up291.47MShs Float83.51Historical High10.78Limit Down1.42%Amplitude3.74Historical Low0.26Dividend TTM11.99Avg Price10.37KlotAsk2.18%Div YieldTTM100Lot Size8.78KlotBid
Cachet Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -37.15%4.68B | -19.93%24.02B | -15.14%18.49B | -13.70%12.84B | 10.17%7.44B | 14.40%30B | 7.43%21.79B | 17.09%14.88B | 4.57%6.76B | 2.32%26.22B |
| Operating revenue | -37.15%4.68B | -19.93%24.02B | -15.14%18.49B | -13.70%12.84B | 10.17%7.44B | 14.40%30B | 7.43%21.79B | 17.09%14.88B | 4.57%6.76B | 2.32%26.22B |
| Other operating revenue | ---- | -53.63%33.96M | ---- | 7.54%96.53M | ---- | --73.25M | ---- | -4.54%89.77M | ---- | --0 |
| Total operating cost | -37.82%4.53B | -19.76%23.48B | -14.97%18.07B | -13.36%12.58B | 10.22%7.29B | 14.81%29.27B | 7.64%21.25B | 17.27%14.52B | 4.96%6.61B | 2.88%25.49B |
| Operating cost | -37.91%4.36B | -19.94%22.43B | -14.52%17.33B | -12.95%12.06B | 11.73%7.02B | 16.20%28.02B | 8.00%20.27B | 18.49%13.85B | 5.65%6.29B | 2.67%24.11B |
| Operating tax surcharges | -36.52%7.04M | -3.68%49.31M | 5.33%40.16M | 15.60%28.64M | 13.43%11.09M | 11.79%51.2M | 7.95%38.13M | 6.60%24.77M | 4.95%9.78M | 2.38%45.8M |
| Operating expense | -49.77%74.96M | -28.42%518.89M | -33.10%396.77M | -30.08%281.46M | -23.83%149.24M | -13.17%724.91M | 5.67%593.1M | -4.57%402.55M | -11.67%195.92M | 4.31%834.82M |
| Administration expense | -9.65%67.22M | 11.42%363.9M | -7.23%211.7M | -6.62%145.95M | -7.80%74.4M | 2.51%326.6M | -3.46%228.21M | 2.04%156.3M | 5.30%80.69M | 10.68%318.61M |
| Financial expense | -28.13%23.01M | -17.98%118M | -22.39%89.67M | -21.70%62.63M | -23.13%32.01M | -19.61%143.87M | -12.52%115.55M | -9.44%79.99M | -2.69%41.64M | 12.62%178.97M |
| -Interest expense (Financial expense) | ---- | -22.34%129.18M | ---- | ---- | ---- | -5.11%166.35M | ---- | ---- | ---- | 14.76%175.31M |
| -Interest Income (Financial expense) | ---- | 37.53%-19.44M | ---- | ---- | ---- | -38.75%-31.12M | ---- | ---- | ---- | -31.01%-22.43M |
| Credit Impairment Loss | -187.81%-38.15M | -9.30%-114.19M | -35.56%-72.54M | -11.63%-52.61M | 21.50%-13.26M | -13.71%-104.47M | -5.24%-53.51M | -106.70%-47.13M | -110.96%-16.89M | -235.36%-91.88M |
| Asset Impairment Loss | -89.36%411.41K | 14.05%-84.49M | 148.14%13.29M | 154.36%11.29M | 356.89%3.87M | -316.20%-98.3M | -258.06%-27.6M | -223.01%-20.77M | -172.50%-1.51M | -8.82%-23.62M |
| Other net revenue | -1,327.77%-35.52M | 118.17%31.75M | 284.64%110.08M | 347.70%123.17M | 71.20%-2.49M | -120.50%-174.78M | -6,262.89%-59.62M | -387.22%-49.72M | -207.79%-8.64M | -336.38%-79.26M |
| Fair value change income | -180.65%-18.65K | 241.18%35.81K | 158.82%14.92K | 138.10%5.97K | 381.82%23.13K | 61.80%-25.36K | 73.44%-25.36K | 70.00%-15.67K | 60.42%-8.21K | 87.12%-66.39K |
| Invest income | -235.67%-325.34K | 101.23%42.73K | 130.59%188.92K | 186.04%427.53K | 201.28%239.8K | -35.19%-3.47M | -471.21%-617.52K | -447.96%-496.9K | ---236.77K | -266.81%-2.57M |
| -Including: Investment income associates | ---- | 36.25%125.56K | ---- | ---- | ---- | 82.47%92.16K | ---- | ---- | ---- | -32.94%50.51K |
| Asset deal income | -84.18%31.89K | 23,721.73%201.43M | 24,507.53%145.68M | 74,181.90%157.16M | 1,305.81%201.59K | -49.40%845.56K | 31.33%592.01K | 574.60%211.57K | -159.93%-16.72K | 126.15%1.67M |
| Other revenue | -60.64%2.53M | -5.63%28.92M | 8.82%23.44M | -62.64%6.9M | -35.72%6.44M | -17.60%30.65M | -32.51%21.55M | -20.85%18.48M | -28.15%10.01M | 27.50%37.2M |
| Operating profit | -27.33%109.38M | 2.11%568.11M | 10.75%534.66M | 23.53%384.96M | 12.90%150.51M | -14.42%556.36M | -11.07%482.77M | -9.60%311.64M | -20.24%133.32M | -21.75%650.1M |
| Add:Non operating Income | -93.53%748.97K | 726.04%21.64M | 173.61%4.09M | 128.72%3M | 3,437.83%11.57M | 126.70%2.62M | 42.30%1.49M | 221.19%1.31M | 29.78%327.01K | 22.72%1.16M |
| Less:Non operating expense | 319.87%2.11M | 929.30%38.08M | 363.79%8.07M | 253.19%4.91M | -32.43%502.81K | -41.71%3.7M | -64.64%1.74M | -35.85%1.39M | 94.71%744.08K | -17.87%6.35M |
| Total profit | -33.15%108.02M | -0.65%551.66M | 9.98%530.68M | 22.95%383.06M | 21.58%161.58M | -13.90%555.28M | -10.48%482.53M | -9.16%311.56M | -20.43%132.9M | -21.73%644.91M |
| Less:Income tax cost | -25.63%32.89M | 28.67%229.99M | 38.27%169.85M | 63.03%130.35M | 25.27%44.22M | 1.22%178.75M | -12.10%122.83M | -8.10%79.96M | -22.62%35.3M | -20.49%176.59M |
| Net profit | -35.98%75.13M | -14.57%321.67M | 0.32%360.83M | 9.11%252.7M | 20.24%117.35M | -19.60%376.53M | -9.91%359.69M | -9.52%231.6M | -19.61%97.6M | -22.19%468.31M |
| Net profit from continuing operation | -35.98%75.13M | -14.57%321.67M | 0.32%360.83M | 9.11%252.7M | 20.24%117.35M | -19.60%376.53M | -9.91%359.69M | -9.52%231.6M | -19.61%97.6M | -22.19%468.31M |
| Less:Minority Profit | -30.70%28.98M | 27.30%161.01M | 5.72%129.86M | 11.00%84.48M | 40.04%41.82M | -26.20%126.47M | -19.27%122.83M | -11.99%76.11M | -29.83%29.86M | -30.90%171.38M |
| Net profit of parent company owners | -38.90%46.15M | -35.75%160.67M | -2.49%230.97M | 8.19%168.22M | 11.51%75.53M | -15.79%250.06M | -4.15%236.86M | -8.26%155.49M | -14.08%67.73M | -16.09%296.94M |
| Earning per share | ||||||||||
| Basic earning per share | -38.46%0.16 | -36.05%0.55 | -2.47%0.79 | 9.43%0.58 | 11.97%0.26 | -15.69%0.86 | -4.71%0.81 | -8.62%0.53 | -14.00%0.2322 | -15.70%1.02 |
| Diluted earning per share | -38.46%0.16 | -36.05%0.55 | -2.47%0.79 | 9.43%0.58 | 11.97%0.26 | -15.69%0.86 | -4.71%0.81 | -8.62%0.53 | -14.00%0.2322 | -15.70%1.02 |
| Other composite income | ||||||||||
| Total composite income | -35.98%75.13M | -14.57%321.67M | 0.32%360.83M | 9.11%252.7M | 20.24%117.35M | -19.60%376.53M | -9.91%359.69M | -9.52%231.6M | -19.61%97.6M | -22.19%468.31M |
| Total composite income of parent company owners | -38.90%46.15M | -35.75%160.67M | -2.49%230.97M | 8.19%168.22M | 11.51%75.53M | -15.79%250.06M | -4.15%236.86M | -8.26%155.49M | -14.08%67.73M | -16.09%296.94M |
| Total composite income of minority owners | -30.70%28.98M | 27.30%161.01M | 5.72%129.86M | 11.00%84.48M | 40.04%41.82M | -26.20%126.47M | -19.27%122.83M | -11.99%76.11M | -29.83%29.86M | -30.90%171.38M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.